-
Generic drugs "increase in volume and decrease in price", and the proportion or decrease in future sales is obvious
Time of Update: 2019-11-14
[pharmaceutical network market analysis] in recent years, driven by volume procurement and generic consistency evaluation, the era of high gross profit in China's generic pharmaceutical industry has p
-
23 batches of drugs stopped selling and recalled (list attached
Time of Update: 2019-10-23
Source: Cypress blue - pharmacy manager arrangement 23 batches of drugs do not meet the requirements, and the tested products involve many pharmacies and hospitals The drug administration requires to
-
China's PD - (L) 1 antibody R & D echelon has been set. If we don't work hard this year, we will become the 18th tier
Time of Update: 2019-04-04
In 2018, the approval and listing of PD - (L) 1 antibodies such as odivo, coreda, tuoyi and dabushu in China ushered in a new era of cancer immunotherapy in China, especially the successful developmen
-
How can pharmaceutical companies benefit from the development of drugs for rare diseases
Time of Update: 2016-10-26
Source: Biovalley 2016-10-26 in recent years, pharmaceutical companies can bring the next 10 for discovery The focus of billion dollar drugs seems to have shifted from drugs for common diseases to new
-
The United States will cooperate with the United Kingdom to speed up the development of new antibiotics
Time of Update: 2016-08-01
Source: nai500 2016-07-29 the United States and the United Kingdom reached a new project to accelerate the development of new antibiotics, with a budget of hundreds of millions of dollars, aimed at so
-
Synthetic pharmaceutical chemicals class 1.1 new drug - Disodium l-ornidazole phosphate - approved clinical trial
Time of Update: 2015-06-24
Announcement of synthetic pharmaceutical industry (832077) on June 23 According to the statement, the company's declared new chemical drug of class 1.1, "disodium l-ornidazole phosphate and disodium l
-
The food and drug department can report the discovery of "black spot" of traditional Chinese medicine when cracking down on weight-added dyeing of traditional Chinese Medicine
Time of Update: 2013-08-13
The reporter learned from the Municipal Food and drug administration that in the near future, the administration will inspect Chinese herbal pieces, Chinese patent medicine manufacturers and the Chine
-
Adjustment of the regulatory layout of Fujian ephedrine in place
Time of Update: 2013-08-05
According to the spirit of the notice on adjusting the distribution of regional wholesale enterprises of narcotic drugs and class I psychotropic drugs issued by the State Food and drug administration,
-
Chinese and foreign enterprises agree on China's latest pharmaceutical innovation plan
Time of Update: 2012-12-07
Source: FDC pharmasia news 2012-12-07 Beijing - according to a report released by the pharmaceutical research and Manufacturers Association of the United States (Pharma), China is likely to become a m
